BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor

Clinical trial pipeline · Data from ClinicalTrials.gov

See which BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06262919

Special Drug Use-results Surveillance of Tafinlar/Mekinist

This is a prospective, multicenter, single-arm, non-interventional and observational J-PMS conducted by the central registration system and operated in Electron…

Japan110 participantsStarted 2024-02-09

Treatment: Tafinlar/Mekinist

BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Special Drug Use-results Surveillance of Tafinlar/Mekinist

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Special Drug Use-results Surveillance of Tafinlar/Mekinist

All recent trials (1 shown)